Stefani Wolff - Aug 16, 2021 Form 3 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
EVP and COO
Signature
/s/ Christine Ring, as Attorney-in-Fact for Stefani Wolff
Stock symbol
NRIX
Transactions as of
Aug 16, 2021
Transactions value $
$0
Form type
3
Date filed
8/17/2021, 05:19 PM
Previous filing
May 18, 2021
Next filing
Jan 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NRIX Employee Stock Option (right to buy) Aug 16, 2021 Common Stock 444K $23.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/4 of the total shares on August 16, 2022, and 1/48 of the total shares vests monthly thereafter until the option is fully vested on August 16, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.